🇺🇸 Clopidogrel 75 in United States
82 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 82
Most-reported reactions
- Dizziness — 13 reports (15.85%)
- Asthenia — 12 reports (14.63%)
- Dyspnoea — 8 reports (9.76%)
- Fatigue — 8 reports (9.76%)
- Gastrointestinal Haemorrhage — 8 reports (9.76%)
- Headache — 8 reports (9.76%)
- Haemoglobin Decreased — 7 reports (8.54%)
- Chest Pain — 6 reports (7.32%)
- Cough — 6 reports (7.32%)
- Diarrhoea — 6 reports (7.32%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Clopidogrel 75 approved in United States?
Clopidogrel 75 does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Clopidogrel 75 in United States?
US Department of Veterans Affairs is the originator. The local marketing authorisation holder may differ — check the official source linked above.